Cover Image

Outcomes of Trabeculectomy With and Without Mitomycin C in Pseudoexfoliative Glaucoma Compared With Mitomycin C in Primary Open Angle Glaucoma

Ana Sofia LOPES, Fernando Trancoso VAZ, Susana HENRIQUES, Maria LISBOA, Cristina VENDRELL, Isabel PRIETO

Abstract


The aim of this study was to evaluate the outcomes of trabeculectomy with mitomycin C (MMC) in patients with Pseudoexfoliative Glaucoma (PXG) and compare the results with the outcomes of trabeculectomy without MMC in PXG and with MMC in Primary Open Angle Glaucoma (POAG). Ninety eyes (76 patients) submitted to trabeculectomy were included in a one-year retrospective study. Fifty-eight eyes with PXG were divided into group 1 (28 eyes) and group 2 (30 eyes), with and without MMC application respectively. Then, the group 1 results were compared with 32 eyes with POAG that performed trabeculectomy with MMC (group 3). Main outcome measures were intraocular pressure (IOP), number of IOP lowering medications, rate of bleb failure (encapsulation, flattening and/or vascularization) and the number of eyes submitted to surgical procedures after trabeculectomy (needling, 5-fluorouracil – 5FU or 2nd trabeculectomy). Results revealed that compared to trabeculectomy with MMC in POAG and trabeculectomy with MMC in PXG, trabeculectomy without MMC in PXG leads to higher IOP (preoperative mean ± standard deviation [SD] was 28.6 ± 5.4 mmHg in group 1, 32.2 ± 8.2 mmHg in group 2 and 26.1 ± 6.5 mmHg in group 3; and after one year was 13.9 ± 3.9 mmHg in group 1, 16.1 ± 5.9 mmHg in group 2 and 12.5 ± 4.0 mmHg in group 3); higher number of IOP lowering medications (preoperative mean was 3.1 ± 0.60 in group 1, 2.8 ± 0.81 in group 2 and 3.4 ± 0.76 in group 3; and after one year was 1.1 ± 1.1 in group 1, 1.1 ± 1.0 in group 2 and 0.33 ± 0.89 in group 3); higher prevalence of bleb failure (47% in group 1, 53% in group 2, and 18% in group 3); and increased participation in surgical procedures following trabeculectomy (47% in group 1, 57% in group 2, and 6% in group 3). We concluded that trabeculectomy without MMC in PXG had the worst surgical outcome. Thus, PXG appears to be a potential risk factor for filtration bleb failure. Therefore, it could be considered in surgical protocols of MMC application.


References


Lim SH, Cha SC. Long-term Outcomes of Mitomycin-C Trabeculectomy in Exfoliative Glaucoma Versus Primary Open-Angle Glaucoma. J Glaucoma. 2017;26(4):303-10. doi: 10.1097/IJG.0000000000000365 pmid: 26709498

Hollo G, Katsanos A, Konstas AG. Management of exfoliative glaucoma: challenges and solutions. Clin Ophthalmol. 2015;9:907-19. doi: 10.2147/OPTH.S77570 pmid: 26045655

Eyewiki - American Academy of Ophthalmology. Pseudoexfoliative Glaucoma 2017 [updated 2019; cited 2018 October 5]. Available from: http://eyewiki.aao.org/Pseudoexfoliative_Glaucoma.

Zenkel M, Schlotzer-Schrehardt U. Expression and regulation of LOXL1 and elastin-related genes in eyes with exfoliation syndrome. J Glaucoma. 2014;23(8 Suppl 1):S48-50. doi: 10.1097/IJG.0000000000000120 pmid: 25275906

Aboobakar IF, Johnson WM, Stamer WD, Hauser MA, Allingham RR. Major review: Exfoliation syndrome; advances in disease genetics, molecular biology, and epidemiology. Exp Eye Res. 2017;154:88-103. doi: 10.1016/j.exer.2016.11.011 pmid: 27845061

Desai MA, Lee RK. The medical and surgical management of pseudoexfoliation glaucoma. Int Ophthalmol Clin. 2008;48(4):95-113. doi: 10.1097/IIO.0b013e318187e902 pmid: 18936639

Sagong M, Gu BY, Cha SC. Association of lysyl oxidase-like 1 gene polymorphisms with exfoliation syndrome in Koreans. Mol Vis. 2011;17:2808-17. pmid: 22128228

Konstas AG, Marshall GE, Lee WR. Iris vasculopathy in exfoliation syndrome. An immunocytochemical study. Acta Ophthalmol (Copenh). 1991;69(4):472-83. doi: 10.1111/j.1755-3768.1991.tb02025.x pmid: 1750316

Koliakos GG, Konstas AG, Schlotzer-Schrehardt U, Hollo G, Mitova D, Kovatchev D, et al. Endothelin-1 concentration is increased in the aqueous humour of patients with exfoliation syndrome. Br J Ophthalmol. 2004;88(4):523-7. doi: 10.1136/bjo.2003.028290 pmid: 15031170

L JL, Hall L, Liu J. Improving Glaucoma Surgical Outcomes with Adjunct Tools. J Curr Glaucoma Pract. 2018;12(1):19-28. doi: 10.5005/jp-journals-10028-1239 pmid: 29861578

Meyer LM, Graf NE, Philipp S, Fischer MT, Haller K, Distelmaier P, et al. Two-year outcome of repeat trabeculectomy with mitomycin C in primary open-angle and PEX glaucoma. Eur J Ophthalmol. 2015;25(3):185-91. doi: 10.5301/ejo.5000542 pmid: 25449638

Hirunpatravong P, Reza A, Romero P, Kim EA, Nouri-Mahdavi K, Law SK, et al. Same-site Trabeculectomy Revision for Failed Trabeculectomy: Outcomes and Risk Factors for Failure. Am J Ophthalmol. 2016;170:110-8. doi: 10.1016/j.ajo.2016.07.018 pmid: 27491696

Fontana H, Nouri-Mahdavi K, Lumba J, Ralli M, Caprioli J. Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma. Ophthalmology. 2006;113(6):930-6. doi: 10.1016/j.ophtha.2006.01.062 pmid: 16647135

Vaz FT, Henriques S, Lopes AS, Silva D, Mota M, Lisboa M. Qual o papel dos anti-metabolitos como adjuvantes intra e pós-operatórios? Glaucoma: Perguntas Frequentes. 4th ed. Portugal: Sociedade Portuguesa de Oftalmologia; 2017.

Chen PP, Yamamoto T, Sawada A, Parrish RK, 2nd, Kitazawa Y. Use of antifibrosis agents and glaucoma drainage devices in the American and Japanese Glaucoma Societies. J Glaucoma. 1997;6(3):192-6. doi: 10.1097/00061198-199706000-00010 pmid: 9211144

Singh K. Antimetabolite application: science or voodoo? J Glaucoma. 1997;6(5):271-3. doi: 10.1097/00061198-199710000-00001 pmid: 9327343

Maquet JA, Dios E, Aragon J, Bailez C, Ussa F, Laguna N. Protocol for mitomycin C use in glaucoma surgery. Acta Ophthalmol Scand. 2005;83(2):196-200. doi: 10.1111/j.1600-0420.2005.00437.x pmid: 15799732

European Glaucoma Society. Secondary Glaucomas. Terminology and guidelines for glaucoma. 4th ed: European Glaucoma Society; 2014. p. 173-4.

Budenz DL, Pyfer M, Singh K, Gordon J, Piltz-Seymour J, Keates EU. Comparison of phacotrabeculectomy with 5-fluorouracil, mitomycin-C, and without antifibrotic agents. Ophthalmic Surg Lasers. 1999;30(5):367-74. pmid: 10334024

Fontana H, Nouri-Mahdavi K, Caprioli J. Trabeculectomy with mitomycin C in pseudophakic patients with open-angle glaucoma: outcomes and risk factors for failure. Am J Ophthalmol. 2006;141(4):652-9. doi: 10.1016/j.ajo.2005.11.039 pmid: 16564799

Jerndal T, Kriisa V. Results of trabeculectomy for pseudo-exfoliative glaucoma. A study of 52 cases. Br J Ophthalmol. 1974;58(11):927-30. doi: 10.1136/bjo.58.11.927 pmid: 4457105

Konstas AG, Jay JL, Marshall GE, Lee WR. Prevalence, diagnostic features, and response to trabeculectomy in exfoliation glaucoma. Ophthalmology. 1993;100(5):619-27. doi: 10.1016/S0161-6420(93)31596-4 pmid: 8493003

Scott IU, Greenfield DS, Schiffman J, Nicolela MT, Rueda JC, Tsai JC, et al. Outcomes of primary trabeculectomy with the use of adjunctive mitomycin. Arch Ophthalmol. 1998;116(3):286-91. doi: 10.1001/archopht.116.3.286 pmid: 9514480

Ehrnrooth P, Lehto I, Puska P, Laatikainen L. Long-term outcome of trabeculectomy in terms of intraocular pressure. Acta Ophthalmol Scand. 2002;80(3):267-71. doi: 10.1034/j.1600-0420.2002.800307.x pmid: 12059864

Landers J, Martin K, Sarkies N, Bourne R, Watson P. A twenty-year follow-up study of trabeculectomy: risk factors and outcomes. Ophthalmology. 2012;119(4):694-702. doi: 10.1016/j.ophtha.2011.09.043 pmid: 22196977

Landa G, Pollack A, Rachmiel R, Bukelman A, Marcovich A, Zalish M. Results of combined phacoemulsification and trabeculectomy with mitomycin C in pseudoexfoliation versus non-pseudoexfoliation glaucoma. Graefes Arch Clin Exp Ophthalmol. 2005;243(12):1236-40. doi: 10.1007/s00417-005-0013-8 pmid: 16003518

Popovic V, Sjostrand J. Course of exfoliation and simplex glaucoma after primary trabeculectomy. Br J Ophthalmol. 1999;83(3):305-10. doi: 10.1136/bjo.83.3.305 pmid: 10365038

Ritch R. Exfoliation syndrome-the most common identifiable cause of open-angle glaucoma. J Glaucoma. 1994;3(2):176-7. doi: 10.1097/00061198-199400320-00018 pmid: 19920577

Kozobolis VP, Papatzanaki M, Vlachonikolis IG, Pallikaris IG, Tsambarlakis IG. Epidemiology of pseudoexfoliation in the island of Crete (Greece). Acta Ophthalmol Scand. 1997;75(6):726-9. doi: 10.1111/j.1600-0420.1997.tb00640.x pmid: 9527341

Aasved H. Prevalence of fibrillopathia epitheliocapsularis (pseudoexfoliation) and capsular glaucoma. Trans Ophthalmol Soc U K. 1979;99(2):293-5. pmid: 298429

Nguyen NX, Kuchle M, Martus P, Naumann GO. Quantification of blood--aqueous barrier breakdown after trabeculectomy: pseudoexfoliation versus primary open-angle glaucoma. J Glaucoma. 1999;8(1):18-23. doi: 10.1097/00061198-199902000-00006 pmid: 10084270


Full Text: Free Full Text PDF

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.